Compounds of the formula (I) are disclosed which are vitronectin receptor antagonists and are useful in the treatment of osteoporosis:
wherein
R
1
is Het or Ar
R
2
is
or a pharmaceutically acceptable salt thereof.
[EN] VITRONECTIN RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DU RECEPTEUR DE LA VITRONECTINE
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2001017959A2
公开(公告)日:2001-03-15
Compounds of formula (I) are disclosed which are vitronectin receptor antagonists and are useful in the treatment of osteoporosis wherein R1 is Het- or Ar; R2 is formula (a) or formula (b); or a pharmaceutically acceptable salt thereof.